December 19, 2025 02:25 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
‘Worst is over,’ says IndiGo CEO after flight chaos; staff told to ignore speculation | Chaos at Hyderabad's Lulu Mall! Nidhhi Agerwal swarmed by fans, police register case | TCS bets big on AI, shares spike as company reveals ambitious plan | Delhi goes into emergency mode! Work from home, vehicle bans as AQI hits ‘severe’ | Massive fire guts shanties near Eco Park in Kolkata; no casualties | Indian Visa Application Centre in Dhaka shuts down early amid rising security concerns | Market update: Sensex tumbles 120 points, Nifty below 25,850 at closing bell | ‘Won’t apologise’: Prithviraj Chavan stands firm on controversial Operation Sindoor remark despite backlash | India summons Bangladesh High Commissioner after provocative 'seven sisters' remark | Amazon eyes $10 billion investment in OpenAI — a gamechanger for AI industry!
Adar Poonawalla
Image Credit: Adar Poonawalla Twitter

Serum Insititute chief Adar Poonwalla to get 'Y-category' security cover

| @indiablooms | Apr 29, 2021, at 02:26 am

New Delhi/IBNS: Pune-based Serum Institute of India's chief Adar Poonawalla will be provided with 'Y-category' security across the country, media reports said.

The order was issued by the Union Home Ministry following an assessment of the threats received by Poonawalla.

"Y category" security means he will be covered by 11 security personnel, out of which one or two of them will be commandos and the rest policemen.

Serum Institute came under heavy criticism after it announced the pricing of its Covishield vaccine to the states for the 18 to 45 age group at Rs. 400 a shot, which is way above the Rs.150 price offered to the Centre.

The revised pricing has provoked anger among many and opposition leaders as well as social media users have demanded "One vaccine one price".

On Wednesday, the Serum Institute announced a 25 per cent reduction in price for the states and will now offer Covishiled at Rs. 300 instead of Rs. 400.

"As a philanthropic gesture on behalf of @SerumInstIndia, I hereby reduce the price to the states from Rs.400 to Rs.300 per dose, effective immediately; this will save thousands of crores of state funds going forward. This will enable more vaccinations and save countless lives," Poonawalla tweeted.
 

 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.